MARKET

CMRAW

CMRAW

Comera Life Sciences
EXMKT
0.0006
NaN%
Closed 09:30 05/23 EDT
OPEN
--
PREV CLOSE
0.0006
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.070
52 WEEK LOW
0.0006
MARKET CAP
--
P/E (TTM)
-0.0012
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CMRAW last week (0512-0516)?
Weekly Report · 5d ago
Weekly Report: what happened at CMRAW last week (0505-0509)?
Weekly Report · 05/12 09:52
Weekly Report: what happened at CMRAW last week (0428-0502)?
Weekly Report · 05/05 09:52
Weekly Report: what happened at CMRAW last week (0421-0425)?
Weekly Report · 04/28 09:57
Weekly Report: what happened at CMRAW last week (0414-0418)?
Weekly Report · 04/21 09:56
Weekly Report: what happened at CMRAW last week (0407-0411)?
Weekly Report · 04/14 09:52
Weekly Report: what happened at CMRAW last week (0331-0404)?
Weekly Report · 04/07 09:52
Weekly Report: what happened at CMRAW last week (0324-0328)?
Weekly Report · 03/31 09:57
More
About CMRAW
Comera Life Sciences Holdings, Inc. is a pre-clinical biotechnology company. The Company applies a knowledge of formulation science and technology to transform biologic medicines from intravenous (IV) to subcutaneous (SQ) forms. The Company is engaged in developing an internal portfolio of therapeutic product candidates using its proprietary formulation platform, SQore. Its proprietary formulation platform, SQore, is designed to transform biologic medicines from intravenous (IV) to subcutaneous (SQ) forms, optimize current versions of subcutaneous biologics, and produce biosimilar versions of existing subcutaneous products. Its product programs include CLS-001, a preclinical stage bio better for Crohn’s and Ulcerative Colitis disease, and CLS-002, a preclinical stage bio better for various oncology indications. It also collaborates with pharmaceutical and biotechnology companies, applying the SQore platform to its partners’ biologic medicines to deliver enhanced SQ formulations.

Webull offers Comera Life Sciences Holdings Inc stock information, including EXMKT: CMRAW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CMRAW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CMRAW stock methods without spending real money on the virtual paper trading platform.